How to use the speech recognition tool?

NCT04285398

PHENOROD2

Prospective Natural History Study of Retinitis Pigmentosa (PHENOROD2)

Type: Observational



Status of the trial: Active, Recruiting

Orphan Drug Recognition: Yes

Inclusion

  • Opening Date: 2020-02-01
  • Closing Date: 2020-03-01

Criteria

Inclusion: RP with mutations affecting the RHO, PDE6A and PDE6B genes Visual acuity ≥ 20/200 for at least one eye Binocular Visual field diameter ≥ 5° as measured on the Goldmann III-4e isopter

Exclusion: Patients with any other gene mutation known to be involved in RP Patients with other ocular disorder likely to impact the visual function Pregnant or breastfeeding women

More information

Children: No

Adults: Yes

Funder Type: private

HCP: Other investigators


Within ERN-EYE members

Principal investigators




Other investigators

Workgroups

  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: